Edit
Ionalytics Corporation
http://www.thermo.com/Last activity: 02.02.2022
Active - Reference to Applied Biosystems
Ionalytics is a developer and provider of a novel front-end separation device for mass spectrometry applications in the fields of proteomics and drug discovery.
August 2005,
August 2005,
Location: United States, Massachusetts, Waltham
Employees: 1-10
Investors 1
| Date | Name | Website |
| - | Genesys Ca... | genesyscap... |
Mentions in press and media 20
| Date | Title | Description |
| 02.02.2022 | Thermo Fisher raises COVID test revenue forecast by $1 billion | By Leroy Leo and Carl O'Donnell (Reuters) -Thermo Fisher Scientific Inc on Wednesday raised its COVID-19 testing revenue guidance for 2022 by $1 billion and said it based its forecasts on an assumption the disease would become endemic from ... |
| 02.02.2022 | Thermo Fisher raises COVID test revenue forecast by $1 billion | Feb 2 (Reuters) - Thermo Fisher Scientific Inc on Wednesday raised its COVID-19 testing revenue guidance for 2022 by $1 billion and said it based its forecasts on an assumption the disease would become endemic from the second half of the ye... |
| 05.01.2022 | Thermo Fisher Scientific completes $1.85B Peprotech acquisition | Thermo Fisher Scientific (NYSE:TMO) announced today that it completed its acquisition of PeproTech for approximately $1.85 billion. Cranbury, New Jersey–based PeproTech develops recombinant proteins, including cytokines and growth factors, ... |
| 02.09.2021 | Thermo Fisher Scientific Receives Award of $192.5 Million U.S. Government Contract to Expand Domestic Pipette Tip Manufacturing | Thermo Fisher Scientific Inc. announced a $192.5 million contract award from the U.S. Department of Defense (DoD) to ensure reliable domestic production of pipette tips, which are used within research and diagnostic labs to dispense precise... |
| 16.04.2021 | Thermo Fisher expands pharma service business with US$17.4 billion PPD acquisition | LONDON: Medical device maker Thermo Fisher Scientific said on Thursday (Apr 15) it would acquire contract researcher PPD for US$17.4 billion as it looks to add more muscle to its pharmaceutical services business. Thermo Fisher, the world's ... |
| 16.04.2021 | Thermo Fisher expands pharma service business with $17.4 billion PPD acquisition | Thermo Fisher, the world's largest maker of scientific instruments, will pay $47.50 per share - a premium of 24% above its $38.36 closing price on Tuesday before news of the deal was first reported. PPD's shares closed on Thursday at $45.80... |
| 15.04.2021 | Thermo Fisher expands pharma service business with $17.4 billion PPD acquisition | By Carl O'Donnell (Reuters) -Medical device maker Thermo Fisher Scientific Inc said on Thursday it would acquire contract researcher PPD Inc for $17.4 billion as it looks to add more muscle to its pharmaceutical services business. Thermo Fi... |
| 15.04.2021 | Thermo Fisher closes in on $15B+ deal for PPD | Thermo Fisher Scientific is nearing a $15 billion-plus acquisition of Wilmington, N.C.-based PPD, a pharmaceutical testing company, The Wall Street Journal reported. Shares in PPD shot up as much as 13% following the news of the potential d... |
| 25.03.2019 | Thermo Fisher gets into gene therapy with $1.7B deal for Brammer Bio | Thermo Fisher Scientific is buying Brammer Bio of Cambridge, Mass., for about $1.7 billion as the giant Waltham, Mass.-based laboratory equipment supplier moves into the fast-growing area of gene therapy. Brammer Bio makes viral vectors tha... |
| 16.05.2011 | Thermo Fisher finally closes $2 billion Dionex deal | After six months of delays, the marriage between Thermo Fisher Scientific Inc. (NYSE:TMO) and Sunnyvale, Calif.-based Dionex Corp. (NSDQ:DNEX) was finally consummated. The deal, first announced Dec. 13, 2010, was beset by several delays in ... |
Show more